TMS denied as duplicate or overlapping therapy by Cigna?

Cigna's specific coverage criteria for tms are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna Denies TMS as Duplicate Therapy — and How to Appeal

Cigna may issue a duplicate-therapy denial for Transcranial Magnetic Stimulation (TMS) when the member is currently receiving another mental-health treatment — most often antidepressant medication or psychotherapy. The plan's logic is that TMS overlaps with an existing therapy addressing the same condition. In practice, this rationale conflates "same diagnosis" with "same mechanism," which is clinically unsound: TMS is a neuromodulation procedure that works through cortical electromagnetic stimulation, a mechanism entirely distinct from pharmacotherapy or talk therapy.

## Why Cigna's Duplicate-Therapy Denial Is Typically Unjustified

Cigna's own medical coverage policies for TMS generally recognize it as a distinct modality. Concurrent medication management is standard practice during a TMS course — the two treatments are complementary, not duplicative. If Cigna's denial letter cites an ongoing medication or therapy as the duplicating treatment, your appeal should make this mechanistic and clinical distinction explicitly. The treating psychiatrist's letter is particularly powerful here.

## Your Federal Appeal Rights

• Internal appeal (ERISA §503 / ACA §2719): File a written internal appeal within the timeframe on your Cigna denial notice. Request the specific coverage criterion used and the credentials of the reviewing clinician.
• External review (ACA §2719): After exhausting Cigna's internal process, you may request an Independent Review Organization (IRO) review. The window is generally around four months from the final internal denial.
• Expedited review: Request expedited timelines at both stages if your treating provider certifies that your condition is urgent.

## Documentation to Gather

1. Diagnosis confirmation — current DSM-5 diagnosis with onset date and severity, documented in chart notes. 2. Current treatment list with rationale — document each ongoing treatment, its purpose, and why it is not providing adequate benefit on its own. 3. Prescriber letter on mechanism distinction — your psychiatrist or treating clinician should explain, in plain language, that TMS and the concurrent treatment work through different mechanisms and serve different clinical purposes. 4. Treatment history with dates and outcomes — shows the inadequacy of prior and current treatments that led to the TMS recommendation. 5. Chart notes — contemporaneous documentation showing that TMS is being added to address a treatment gap, not to duplicate an existing treatment.

## Criteria-Mapping Structure

Locate Cigna's TMS medical coverage policy in their online policy library (search "transcranial magnetic stimulation" in Cigna's coverage policy portal). For each criterion related to duplicate therapy:

| Cigna Policy Criterion | Your Supporting Evidence | |---|---| | TMS is a distinct modality | Prescriber letter explaining mechanism difference | | Current treatment is insufficient | Progress notes + scale scores showing inadequate response | | TMS addresses a separate clinical need | Specific clinical rationale from treating clinician | | Diagnosis confirmation | Chart note + DSM-5 code |